X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Drug Discharge Seen In NYC As Consequences Of Heavy Rainfall

Content Team by Content Team
27th June 2024
in News
Drug Discharge Seen In NYC As Consequences Of Heavy Rainfall

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

In the US, nearly 100 million individuals are prescribed medications like metoprolol and atenolol to lower their blood pressure. Unintentionally, some of these drugs are finding their way into US waterways. Recent research highlights that pharmaceuticals, recreational drugs, and their byproducts are present in the Hudson and East Rivers in New York City after heavy rains, suggesting this issue may be widespread.

Human bodies do not fully metabolize many drugs, leading to their excretion in urine. This urine typically flows to wastewater treatment plants, which vary in how effectively they remove drug contaminants. Marta Concheiro-Guisan, a forensic toxicologist at the John Jay College of Criminal Justice and one of the study’s authors, explains that New York City and other major US cities use outdated combined wastewater and stormwater systems. During heavy rainfall, these systems can overflow, sending untreated, drug-laden waste directly into rivers. Modern sewer systems, which separate wastewater and stormwater, avoid such overflows.

Blood pressure medications were detected at the highest concentrations, but other drugs, including the antidepressant fluoxetine and the antibiotic sulfamethoxazole, were also found. Recreational drugs like cocaine, methamphetamine, methadone, and fentanyl, along with their byproducts, were present as well. These substances were detected at levels ranging from 0.5 ng/L to about 100 ng/L. Scientists refer to these concentrations as micropollutants, though there is no US policy officially defining them.

The impact of these drug micropollutants on people and the environment remains unclear. Lloyd Wilson, an environmental toxicologist at the University at Albany, notes that more data is needed to understand potential consequences. He believes that, generally, the detected levels do not pose a significant human health risk but emphasizes that ongoing contaminant monitoring is essential to track their effects.

Previous Post

Innovative Strategies For A Greener Pharmaceutical Sector

Next Post

Harnessing Wastewater For Disease Detection And Management

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
Harnessing Wastewater For Disease Detection And Management

Harnessing Wastewater For Disease Detection And Management

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In